Carnegie Mellon University Master of Software Engineering Program Partners with Retail Technology Platform Surefront
The retail technology platform and the engineering program team up to develop innovative engineering and design solutions with market-wide impacts. LOS ANGELES–(BUSINESS... Read more.
IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments
Significant throughput of LSA to advance IPA’s diversity- and data-driven drug development and to enrich LENSai™. VICTORIA, British Columbia–(BUSINESS... Read more.
Centrico Spa (Sella Group) and Veracode Collaborate to Help Secure the Application Development Life Cycle
The Companies Will Collaborate to Enhance the Analysis and Development of Secure Code MILAN–(BUSINESS WIRE)–#AppSec—Centrico Spa, part of Sella... Read more.
Palliser Appoints Former Elliott Partner Steve Kasoff as Chairman of Palliser US
LONDON–(BUSINESS WIRE)–Palliser Capital, a global multi-strategy investment firm, announced today that former Elliott Management Equity Partner and Senior... Read more.
Prime Insurance Company Defeats Frivolous Litigation
Court Agrees and Rules in Favor of Liability Waivers SALT LAKE CITY–(BUSINESS WIRE)–Rick J. Lindsey, President and CEO of Prime insurance Company announced... Read more.
Modern Health Welcomes Steve Fitz As New Chief Revenue Officer
Modern Health Accelerates Into Its Next Phase of Growth With Strategic New Hire SAN FRANCISCO–(BUSINESS WIRE)–Modern Health, a leading global workplace... Read more.
Primmune Therapeutics Secures $22.5 Million Contract from Defense Threat Reduction Agency (DTRA) to Advance PRTX007 for Treatment of Lassa Fever
– PRTX007 program to support DTRA’s efforts to establish biological defense solution against Lassa fever and other hemorrhagic viruses – SAN DIEGO–(BUSINESS... Read more.
N-able Recognized for Two Comparably Best Places to Work Awards
N-ablites rate the company highly for Best Company Outlook and Best HR Teams BURLINGTON, Mass.–(BUSINESS WIRE)–N-able, Inc. (NYSE: NABL), a global software... Read more.
Bristol Myers Squibb Announces CheckMate -9DW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Meets Primary Endpoint of Overall Survival for the First-Line Treatment of Advanced Hepatocellular Carcinoma
Opdivo plus Yervoy demonstrates statistically significant and clinically meaningful improvement in overall survival compared to investigator’s choice of sorafenib... Read more.
Chemours and Partners Selected for $60M in U.S. Department of Energy Grants to Support Continued Advancement of Global Hydrogen Economy
Two project grants will support development of next-generation membranes for PEM water electrolysis and developing a circularity infrastructure for clean hydrogen... Read more.